Regency Fincorp board meets September 2 to approve FY26 results
- Board meeting scheduled for September 2, 2026, to approve FY26 results
- Agenda includes AGM notice and calendar of events for FY26
- Directors to approve increased borrowing and NCD issuance limits
- Proposal to increase authorized share capital and alter MOA
- Approval sought for new Employee Stock Option Scheme

*this image is generated using AI for illustrative purposes only.
Regency Fincorp has scheduled a Board of Directors meeting for September 2, 2026, to consider and approve the financial results for the fiscal year ended March 31, 2026. The company will also finalize the calendar of events and issue the notice for its Annual General Meeting (AGM).
The agenda includes strategic capital management decisions, such as approving the borrowing limit under Section 180(1)(c) of the Companies Act, 2013. The board will also review the proposed increase in the Non-Convertible Debenture (NCD) issuance limit.
Capital Structure and Employee Incentives
The meeting will address changes to the company’s capital structure. Directors are set to consider an increase in the authorized share capital, along with the consequential alteration of the Memorandum of Association.
Additionally, the board will approve the issuance of Employee Stock Options (ESOPs) to eligible staff under a proposed scheme. This move aligns employee incentives with long-term shareholder value creation.
Regulatory Compliance
The intimation was issued pursuant to Regulation 29 of Chapter IV and Regulation 50 of Chapter V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Abhimanyu, Company Secretary and Compliance Officer, signed the disclosure on August 27, 2026.
Historical Stock Returns for Regency Fincorp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.35% | +2.91% | +13.19% | +63.93% | +21.65% | +750.27% |
How might the proposed increase in the NCD issuance limit impact Regency Fincorp's debt-to-equity ratio and overall leverage profile?
What specific strategic initiatives or expansion plans is Regency Fincorp likely funding with the approved borrowing limits and capital structure changes?
Could the new ESOP scheme lead to significant short-term dilution for existing shareholders, and how is the vesting period structured to align with long-term performance?


































